锡纳林作为一种强大的抗骨解剂:向MAPK和Nrf2-Keap1通路,以抑制骨质细胞和保护骨
Rui Chao1, Yexin Wang1, Zhan Liu1
1Department of Oral Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200011, P.R. China.
International journal of molecular medicine
|September 26, 2025
概括
锡纳林有效地通过抑制骨质细胞活性和炎症来治疗炎症性骨损失. 它还可以改善骨结构并激活保护性通路,显示了骨质解体的治疗潜力.
科学领域:
- 生物化学 生物化学
- 细胞生物学 细胞生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 由骨质细胞过度激活驱动的炎症性骨再吸收,对健康构成重大风险.
- 素是一种天然的抗炎化合物,已在各种炎症疾病中显示出治疗潜力.
- 锡纳林在炎症性骨再吸收中的特殊作用需要详细的研究.
研究的目的:
- 为了研究cynarin在炎症性骨再吸收中的治疗潜力.
- 阐明素对骨质细胞分化,炎症反应和相关信号通路的调节作用.
主要方法:
- 在体外研究中评估了骨质细胞分化标志物和炎症反应.
- RNA测序和西部斑分析确定了关键信号通路,包括MAPK和Nrf2.
- 在体内研究中,在小鼠模型中使用微型计算机断层扫描和组织学分析.
主要成果:
- 锡纳林显著抑制了骨质细胞分化和骨再吸收.
- 锡纳林抑制了MAPK通路激活和炎症性细胞因子表达,同时激活了Nrf2.
- 在体内,素改善了骨结构,调节了骨质细胞和炎症标志物.
结论:
- 锡纳林显示出对炎症性骨再吸收的多方面的治疗潜力.
- 锡纳林通过抑制骨质细胞形成,抑制炎症和激活Nrf2抗氧化途径来发挥作用.
- 这些发现凸显了素作为治疗具有定义分子标的炎症性骨质溶解的有希望的药物.
相关概念视频
Inhibition of Cdk Activity
5.5K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.5K
Osteoclasts in Bone Remodeling
3.9K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.9K

